Literature DB >> 25119570

[Soft tissue tumors : Imaging strategy for local primary diagnostics - manifestation, pearls and pitfalls in MRI].

I-M Nöbauer-Huhmann1.   

Abstract

Only approximately 1% of soft tissue tumors are malignant. Potentially malignant lesions can be recognized by ultrasound and submitted for magnetic resonance imaging (MRI). Radiography can supply valuable additional information. The MRI examination is the imaging reference standard for soft tissue tumors and also serves as local staging modality. Lesions which are indeterminate in MRI, or in which therapy is dependent on histology results, should be biopsied. Referral to a reference center is recommended. The multitude of soft tissue tumor entities are classified according to the World Health Organization (WHO) system (latest version 2013). Some tumors show characteristic locations and MRI morphology. Sarcoma staging by imaging is influenced by the size and site in comparison to the surface fascia. International standards must be adhered to: decisive for the patient is in particular the care by an experienced interdisciplinary tumor team.

Entities:  

Mesh:

Year:  2014        PMID: 25119570     DOI: 10.1007/s00117-014-2699-2

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  20 in total

Review 1.  Imaging of intraarticular masses.

Authors:  Patrick J Sheldon; Deborah M Forrester; Thomas J Learch
Journal:  Radiographics       Date:  2005 Jan-Feb       Impact factor: 5.333

2.  [Guidelines for the biopsy of bone and soft tissue tumours].

Authors:  A Leithner; R Windhager
Journal:  Orthopade       Date:  2007-02       Impact factor: 1.087

Review 3.  Magnetic resonance imaging of soft-tissue tumors: determinate and indeterminate lesions.

Authors:  Derek F Papp; A Jay Khanna; Edward F McCarthy; John A Carrino; Adam J Farber; Frank J Frassica
Journal:  J Bone Joint Surg Am       Date:  2007-10       Impact factor: 5.284

Review 4.  Peripheral tumor and tumor-like neurogenic lesions.

Authors:  Evandro Abreu; Sébastien Aubert; Guillaume Wavreille; Ramon Gheno; Clarissa Canella; Anne Cotten
Journal:  Eur J Radiol       Date:  2011-05-10       Impact factor: 3.528

5.  The symptom-to-diagnosis delay in soft tissue sarcoma influence the overall survival and the development of distant metastasis.

Authors:  Tomoki Nakamura; Akihiko Matsumine; Takao Matsubara; Kunihiro Asanuma; Astumasa Uchida; Akihiro Sudo
Journal:  J Surg Oncol       Date:  2011-07-08       Impact factor: 3.454

6.  Elastofibroma in Okinawa. A clinicopathologic study of 170 cases.

Authors:  N Nagamine; Y Nohara; E Ito
Journal:  Cancer       Date:  1982-11-01       Impact factor: 6.860

Review 7.  Soft-tissue tumors and tumorlike lesions: a systematic imaging approach.

Authors:  Jim S Wu; Mary G Hochman
Journal:  Radiology       Date:  2009-11       Impact factor: 11.105

8.  Magnetic resonance imaging of soft tissue tumors.

Authors:  A M De Schepper; F A Ramon; H R Degryse
Journal:  J Belge Radiol       Date:  1992-08

9.  A consecutive 7-year series of 1331 benign soft tissue tumours. Clinicopathologic data. Comparison with sarcomas.

Authors:  O Myhre-Jensen
Journal:  Acta Orthop Scand       Date:  1981-06

Review 10.  MRI characteristics and classification of peripheral vascular malformations and tumors.

Authors:  Hicham Moukaddam; Jeffrey Pollak; Andrew H Haims
Journal:  Skeletal Radiol       Date:  2008-11-20       Impact factor: 2.199

View more
  1 in total

Review 1.  [Soft tissue sarcoma: how can posttreatment alterations be distinguished from recurrences?]

Authors:  I-M Noebauer-Huhmann; T Grieser
Journal:  Radiologe       Date:  2017-11       Impact factor: 0.635

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.